CTS Launches "Rageon + Ashwagandha" and Expands its Nutritional Supplement Range

Especially in complex and tense times like those we have experienced in recent years, feelings of calm and relaxation are extremely important.

CTS, one of the oldest and leading players in the Israeli pharma market, is launching a new product in the Rageon series, based on plants such as passionflower and lemon balm, this time with the addition of ashwagandha - a well-known adaptogenic plant that contributes to natural relaxation and coping with daily stress. The new product comes in a refreshing packaging design, as part of a comprehensive rebranding process for the Hadas nutritional supplement brand.

CTS's expansion into the field of nutritional supplements began with the acquisition of Flourish and its production plant in the north of the country at the beginning of 2023, and is gaining momentum with the expansion of the product portfolio, the development of new series and the deepening of activity in the field of nutritional supplements.

All Flourish products have been unified under the "Hadas" brand, with a sharpened brand identity and a clear connection to the values of quality, science and medical reliability, as part of CTS's DNA since 1921.

"Rageon + Ashwagandha" is the first sign of a new wave of launches, which aims to strengthen CTS's presence in the Israeli nutritional supplement market, with products based on scientific knowledge, local production and the standards of a pharmaceutical company.

Recommended retail price 69.90 NIS.

Photo = "Rageon + Ashwagandha" by CTS. Photo courtesy of CTS Co.